First Time Right.
We develop scalable, robust and GMP-compliant manufacturing processes for recombinant proteins and antibodies.
- Upstream Process Development
- Downstream Process Development
- Analytical Development
- In Silico Cost Modeling
Optimize your protein expression with our upstream process development for recombinant proteins and antibodies.
Our expertise encompasses selecting a suitable host cell line and optimizing conditions for high-yield protein expression.
Ensuring high levels of protein expression is crucial for cost-effectiveness, scalability, and meeting regulatory requirements for product quality. Additionally, optimizing protein expression also helps to minimize impurities and reduce the complexity of downstream purification, which further contributes to the overall success of your process development.
Develop improved or completely novel purification processes.
In downstream process development for recombinant proteins and antibodies, developing an efficient and effective purification strategy is pivotal. We typically adhere to Design of Experiments (DoE) and Quality by Design (QbD) tools to efficiently anchor purification steps and monitor the key process parameters for scale-up.
A well-designed purification process can result in a high-quality and pure final product, meeting regulatory requirements, and ensuring the desired therapeutic efficacy. Additionally, optimizing the downstream process can also help to increase product yields, reduce costs, and improve the scalability of the manufacturing process.
Establish robust and reliable analytical methods to ensure the quality, identity, purity, and stability of your product.
Our expertise includes developing methods for quantifying your protein, characterizing its structure, determining the presence of impurities, and monitoring stability during storage and transportation.
Robust analytical methods are critical for ensuring that your product meets regulatory requirements, and providing the data needed to make informed decisions about product development and manufacturing.
Make well-informed decisions quickly with In silico Modeling.
Our in silico expertise saves time and resources during the development phase and manufacturing of recombinant proteins. The software integrates up-to-date information from across the biopharmaceutical sector with the latest industry-benchmarked price information for materials, consumables and equipment.
With our in silico modeling expertise and software systems, we are able to save significantly on manufacturing costs by understanding cost structures early in the development of non-platform processes and platform processes.
Technologies for Recombinant Protein & Antibody Development & Manufacturing
Improve product yield, reduce process development time & increase product stability.